Kane Biotech Inc. (KNE.V)
| Previous Close | 0.1350 |
| Open | 0.1300 |
| Bid | 0.1200 x 0 |
| Ask | 0.1300 x 0 |
| Day's Range | 0.1300 - 0.1300 |
| 52 Week Range | 0.0600 - 0.1700 |
| Volume | |
| Avg. Volume | 151,604 |
| Market Cap | 17.227M |
| Beta (5Y Monthly) | 0.52 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0300 |
| Earnings Date | Nov 26, 2024 - Dec 02, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireKane Biotech to Participate in a Multinational Corporate Collaboration Project
WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and up to $75,000 in funding through the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to collaborate on a research and development project with a multinational corporate partner. The goal of the collaboration project is to develop a Proof-of Concept for its DispersinB®
- GlobeNewswire
Kane Biotech Announces Attendance at Upcoming Wound Care Conferences
WINNIPEG, Manitoba, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the Company will be showcasing its revyve™ Antimicrobial Wound Gel and revyve™ Antimicrobial Wound Gel Spray products at the following wound care conferences: Symposium on Advanced Wound Care (SAWC) (October 2-5, 2024 in Las Vegas Nevada) where Kane will be presenting research on the antibiofilm properties and compatibility with different dre
- GlobeNewswire
Kane Biotech Announces Exercise of Warrants
WINNIPEG, Manitoba, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces the exercise of an aggregate of 5 million warrants at an exercise price of $0.10 per common share for total proceeds of $500,000. “The shares are being held by some long-term supporters of Kane,” said Marc Edwards, President & CEO. The proceeds from these warrant exercises will be used for general working capital purposes. About Kane Biotech Kane Biotech Inc. is
